Well Told Grants

Federal grant recipients / Arkansas

Federal grants to Nephropathology Associates, PLC

Little Rock, Arkansas · Small businesses · UEI LFE7CWNKK1X3

Nephropathology Associates, PLC in Little Rock, Arkansas received $5.2 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $4.6 million. In fiscal 2025 more was taken back from its awards than added, a net -$35,963.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Nephropathology Associates, PLC by fiscal year
Fiscal yearAwardsAmount
FY 20213$767,572
FY 20224$1.7 million
FY 20232$1.9 million
FY 20241$933,992
FY 20250-$35,963

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Nephropathology Associates, PLC

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8475$4.6 million
Allergy and Infectious Diseases Research 93.8551$366,107
Arthritis, Musculoskeletal and Skin Diseases Research 93.8461$243,088

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services7$5.2 million

Largest awards

The 7 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Development of a precision medicine-based diagnostic tool for membranous nephropathy - project summary the goal of this program is to initiate commercialization of a mass spectrometry (MS)-based workflow for the diagnosis and classification of membranous nephropathy (MN), a leading cause of nephroti
ASST_NON_R44DK130702_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 12, 2022$2.0 million
A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases - project summary the goal of this direct to phase II program is to develop and test the efficacy of a precision medicine clinical trials enrollment platform for kidney dise
ASST_NON_R44DK138688_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 15, 2023$1.9 million
Predictive biomarkers of treatment response in kidney transplant rejection - project summary the overall purpose of this proposal is to develop predictive biomarkers of treatment outcome in kidney transplant rejection, specifically in t-cell mediated rejection (TCMR), as the response to treatment ca
ASST_NON_R21AI151491_075 on USAspending
Allergy and Infectious Diseases ResearchDecember 4, 2020$366,107
Rapid genotyping of APOL1 risk alleles using CRISPR-CAS12A - summary. African americans are disproportionately affected by chronic and end stage renal disease (ESRD); while 35% of patients on dialysis are african american, only 13.2% of the U.S. Population is african american. A major factor contrib
ASST_NON_R43DK131737_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 8, 2021$253,103
Smartphone image analysis for real time adequacy assessment during kidney biopsy - summary. The goal of this project is to develop image analysis tools that can be deployed as a smartphone application to aid in the real time assessment of biopsy adequacy during percutaneous renal biopsy (PRB) proced
ASST_NON_R43DK134273_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchSeptember 12, 2022$252,144
Development of specific peptide reagents for serologic monitoring of exostosin autoantibodies in membranous lupus nephritis - project summary up to half of patients with systemic lupus erythematosus (SLE) will develop lupus nephritis (LN), and nearly a third of ln patients will develop kidney failur
ASST_NON_R43AR081720_075 on USAspending
Arthritis, Musculoskeletal and Skin Diseases ResearchSeptember 2, 2022$243,088
Development of a precision medicine-based diagnostic tool for membranous nephropathy - summary/abstract the goal of this project is to develop a precision medicine approach to the rapid diagnosis of membranous nephropathy (MN) using automated statistical analysis of proteomic data obtained from kidn
ASST_NON_R41DK130702_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchJuly 2, 2021$231,173

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Nephropathology Associates, PLC get?

$5.2 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Nephropathology Associates, PLC the most?

The Department of Health and Human Services, with $5.2 million in 7 awards.

What is Nephropathology Associates, PLC's largest federal grant?

$2.0 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on September 12, 2022. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Nephropathology Associates, PLC?

Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Allergy and Infectious Diseases Research and Arthritis, Musculoskeletal and Skin Diseases Research.

Other grant recipients in Little Rock

Largest federal grant recipients in Arkansas · Federal grants in Arkansas